KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PRPH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

ProPhase Labs stock price ended at $4.71 on Friday, after losing 4.85%.
(Updated on Apr 26, 2024)

Sell candidate since Apr 18, 2024 Loss -13.42% PDF

The ProPhase Labs stock price fell by -4.85% on the last day (Friday, 26th Apr 2024) from $4.95 to $4.71. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 7.59% from a day low at $4.60 to a day high of $4.95. The price has fallen in 8 of the last 10 days and is down by -27.76% for this period. Volume has increased on the last day by 48 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 60 thousand shares were bought and sold for approximately $282.33 thousand.

Given the current short-term trend, the stock is expected to rise 21.50% during the next 3 months and, with a 90% probability hold a price between $5.72 and $9.14 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PRPH Signals & Forecast

There are few to no technical positive signals at the moment. The ProPhase Labs stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.07 and $5.79. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 16, 2024, and so far it has fallen -35.92%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). ProPhase Labs gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for ProPhase Labs stock

ProPhase Labs finds support from accumulated volume at $4.59 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.349 between high and low, or 7.59%. For the last week, the stock has had daily average volatility of 7.17%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PRPH) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect ProPhase Labs to open at $4.75, and during the day (based on 14 day Average True Range), to move between $4.22 and $5.20, which gives a possible trading interval of +/-$0.487 (+/-10.34%) up or down from last closing price. If ProPhase Labs takes out the full calculated possible swing range there will be an estimated 20.69% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.59 (2.55%) than the resistance at $4.95 (5.10%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is ProPhase Labs stock A Buy?

The ProPhase Labs stock holds several negative signals and despite the positive trend, we believe ProPhase Labs will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.588 Sell Candidate Unchanged

Predicted Opening Price for ProPhase Labs of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$4.75 ( 0.93%) $4.71

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PRPH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.10 8.34 %
R2 4.97 5.51 %
R1 4.89 3.76 %
Current price: 4.71
Support S1 4.62 -1.90 %
S2 4.54 -3.65 %
S3 4.40 -6.49 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.44 15.50 %
R2 5.26 11.68 %
R1 4.95 5.10 %
Current price 4.71
Support S1 4.59 -2.55%
S2 4.56 -3.18%
S3 4.47 -5.10%

PRPH Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 13, 2022 May 24, 2022 Jun 03, 2022 $0.300 3.05%
2 Feb 16, 2022 Feb 28, 2022 Mar 10, 2022 $0.300 4.55%
3 May 13, 2021 May 24, 2021 Jun 03, 2021 $0.300 6.04%
4 Nov 20, 2019 Dec 02, 2019 Dec 12, 2019 $0.250 11.85%
5 Dec 26, 2018 Jan 09, 2019 Jan 24, 2019 $0.250 8.25%

FAQ

What is the symbol for ProPhase Labs Stock and on which exchange is it traded?
The symbol for ProPhase Labs is PRPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ProPhase Labs Stock?
The ProPhase Labs stock holds several negative signals and despite the positive trend, we believe ProPhase Labs will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy ProPhase Labs Stock?
ProPhase Labs Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ProPhase Labs Stock.

What's the current price of ProPhase Labs Stock?
As of the end of day on the Apr 26, 2024, the price of an ProPhase Labs (PRPH) share was $4.71.

What is the 52-week high and low for ProPhase Labs Stock?
The 52-week high for ProPhase Labs Stock is $9.90 and the 52-week low is $4.05.

What is the market capitalization of ProPhase Labs Stock?
As of the Apr 26, 2024, the market capitalization of ProPhase Labs is 89.324M.

When is the next earnings date for ProPhase Labs?
The upcoming earnings date for ProPhase Labs is May 09, 2024.
Click to get the best stock tips daily for free!

About ProPhase Labs

ProPhase Labs ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also prov... PRPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT